ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
12/18/2024
Back to search
Official data from USPTO
GENICIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
12/18/2024
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
11/14/2013
Registration date
06/24/2014
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/03/2024
Last transaction
06/03/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
12/01/2011
First use in commerce
12/01/2011
Drawing code
3
Owner type
16
Owner location
LOS ANGELES, CA, US
Examiner
GALAN, MATTHEW
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the term "GENICIN" in red stylized font. Above the second letter "I", there is a single red leaf blowing north east at roughly a 45 degree angle. Within the leaf there is a single white line in the middle of the leaf following the same direction of the leaf. Just within the borders of the leaf there are thin white lines following the shape of the leaf.
Holders and representatives
Holders
S.A.A.A INVESTMENTS, LLC.
Alexso, Inc.
Alexso, Inc.
Representatives
S.A.A.A INVESTMENTS, LLC.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pain relief medication; Pharmaceutical preparations for the prevention of degenerative joint disease; Pharmaceutical preparations for the treatment and prevention of degenerative joint disease; Pharmaceutical preparations for the treatment of degenerative joint disease; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorderssports related injuriesfor knee cartilage regeneration; Pharmaceutical preparations for use in treating and preventing degenerative joint disease; Pharmaceutical preparationsa drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease
Publications
History of USPTO decisions and trademark events.
44 publications found
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
09/18/2024
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
06/03/2024
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
06/03/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/03/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
05/17/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
05/01/2024
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
04/30/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
04/24/2024
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
04/23/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/23/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/27/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
12/20/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/24/2023
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
08/12/2019
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
08/12/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/12/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/26/2019
ES8R
TEAS SECTION 8 RECEIVED
07/26/2019
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/24/2019
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
06/12/2015
PLGL
ASSIGNED TO PARALEGAL
06/12/2015
ES7R
TEAS SECTION 7 REQUEST RECEIVED
06/11/2015
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/11/2015
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/04/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
06/24/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/08/2014
PUBO
PUBLISHED FOR OPPOSITION
04/08/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/19/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/06/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/05/2014
XAEC
EXAMINER'S AMENDMENT ENTERED
03/05/2014
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/05/2014
GNEA
EXAMINERS AMENDMENT E-MAILED
03/05/2014
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/05/2014
CEPE
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
03/05/2014
ALIE
ASSIGNED TO LIE
03/04/2014
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
03/04/2014
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
03/04/2014
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
03/04/2014
DOCK
ASSIGNED TO EXAMINER
03/01/2014
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/28/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/27/2013
NWAP
NEW APPLICATION ENTERED
11/18/2013
Continuous trademark protection
Get notified about every new filing that threatens GENICIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.